NASDAQ: AVLNAvalyn Pharma Inc Stock Ownership - Who owns Avalyn Pharma?
Insider buying vs selling
Have Avalyn Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jill Carroll | Director | 2026-05-01 | 277,778 | $18.00 | $5.00MBuy |
| Holdings A. Novo | 10% Owner | 2026-05-01 | 555,555 | $18.00 | $10.00MBuy |
| Sr One Capital Management LLC | 10% Owner | 2026-05-01 | 277,778 | $18.00 | $5.00MBuy |
| Sr One Capital Management LLC | 10% Owner | 2026-05-01 | 277,777 | $18.00 | $5.00MBuy |
AVLN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AVLN insiders and whales buy or sell their stock.
AVLN Shareholders
What type of owners hold Avalyn Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Holdings A. Novo | 8.76% | 3,883,289 | $133.12M | Insider |
| Sr One Capital Management LLC | 7.46% | 3,308,649 | $113.42M | Insider |
| Fmr LLC | 5.15% | 2,284,535 | $78.31M | Insider |
| Jill Carroll | 4.93% | 2,186,562 | $74.96M | Insider |
| Wellington Biomedical Innovation Master Investors Cayman II LP | 2.88% | 1,275,486 | $43.72M | Insider |
| Fidlty | 0.01% | 5,835 | $200.02k | Institution |
| Fmr LLC | 0.01% | 5,835 | $200.02k | Institution |
| Novo Holdings A | 0.01% | 3,883 | $133.11k | Institution |
| Novoho | 0.01% | 3,883 | $133.11k | Institution |
| Sronec | 0.01% | 3,309 | $113.43k | Institution |
AVLN vs Biotech Stocks
Avalyn Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.